z-logo
Premium
Geography: an increasingly important variable in prostate cancer clinical trials
Author(s) -
Sartor Oliver,
Pal Sumanta Kumar,
Hermanson Terhi,
Bennett Charles L.
Publication year - 2015
Publication title -
bju international
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.12930
Subject(s) - enzalutamide , cohort , docetaxel , medicine , placebo , prostate cancer , european union , post hoc analysis , clinical trial , oncology , cancer , pathology , androgen receptor , alternative medicine , business , economic policy

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom